Connect with us
Eli Lilly will invest $3 billion to build a new oral medication plant in Katwijk, Netherlands, creating 500 jobs. The facility will produce treatments for obesity,...
Eli Lilly will invest $3 billion to expand its Kenosha, Wisconsin, facility, acquired for $100 million in April. The site will manufacture injectable diabetes and obesity...
Eli Lilly posted a $970.3 million profit in Q3, boosted by 20.4% growth in sales despite a $1 billion loss in market value. Oversupply issues arose...
Eli Lilly is expanding its presence with the opening of a 346,000-square-foot facility in Boston, which will house 500 scientists and the first East Coast location...
Eli Lilly's first-half 2023 revenues surged 31% to $20 billion, driven by Mounjaro's $4.9 billion in sales, dominating the company’s earnings. Trulicity, in contrast, saw a...
Augustine Therapeutics raised 17 million euros in the first closing of a Series A round led by Asabys Partners. Eli Lilly & Company and the CMT...
Eli Lilly is investing $5.3 billion in a new Indiana plant to increase production of diabetes and weight loss drugs, raising total facility investment to $9...
Eli Lilly's first-quarter results exceeded expectations, with a $8.77 billion turnover, a 26% year-on-year growth, and $2.24 billion net income, 67% higher than in 2023. Strong...
Eli Lilly's U.S. revenues grew by 39% to 6,188.1 million euros, with international revenues up 10% to 2.7 billion euros. R&D costs rose by 29.5%, while...
The pharmaceutical company Eli Lilly has added that it will invest $100 million with the aim of boosting its footprint in the German biotechnology ecosystem. The...